RT - Journal TY - JOUR A1 - Kakati, Kaberi A1 - Rahman, Tashnin A1 - Barman, Debabrata A1 - Bhattacharyya, Mouchumee A1 - Borthakur, Bibhuti A1 - Barman, Rashmisnata A1 - Kalita, Apurba A1 - Kataki, Amal A1 - Krishnatreya, Manigreeva T1 - Mortality audit of 19 patients with cancer and SARS-CoV-2 positivity YR - 2022/1/1 JF - Journal of Current Oncology JO - J Curr Oncol SP - 21 OP - 24 VO - 5 IS - 1 UL - http://www.https://journalofcurrentoncology.org//article.asp?issn=2589-8892;year=2022;volume=5;issue=1;spage=21;epage=24;aulast=Kakati;t=5 DO - 10.4103/jco.jco_3_22 N2 - Introduction: Coronavirus disease-2019 (COVID-19) has disrupted cancer care services globally. The main objective of this study was to review the cause of deaths in admitted patients with cancer with positive report for severe acute respiratory syndrome coronavirus – 2 (SARS-CoV-2). Materials and Methods: The present review of the cause of deaths was conducted in a tertiary care cancer center in the North East India. In our institute, all cancer patients requiring admission for surgery, chemotherapy, and other daycare procedures require testing for SARS-CoV-2. Results: From 9 July 2020 to 16 May 2021, 119 cancer patients with SARS-CoV-2 positive report or COVID-19 have been admitted to our institute COVID ward. A total of 19 cancer patients with COVID-19 succumbed. Of 19 deaths, 13 (68.4%) patients were men and 6 (31.6%) patients were women. The age range was from 27 years to 74 years (median =55 years). Vomiting alone or with diarrhea was the most common symptom requiring admission after testing (4/19, 21.0%), followed by bleeding from the primary tumor site (3/19, 15.7%). Conclusion: The antecedent and underlying cause of deaths in 19 (100%) patients was cancer. SARS-CoV-2 infection should not be a hindrance to cancer treatment and management. ER -